Evidence map›Paper›PMID 42376545›Full record

ArticleOpen veterinary journal2025

Anticancer properties of ethanolic extract of Omani

Juma Al-Mutaani, Tahani Zorgui, Lazhar Zourgui, Omar Alqawi, Nabiha Missaoui

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juma Al-MutaaniResearch Laboratory LR21ES03, Oncogenesis and Tumor Progression, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
Tahani ZorguiResearch Laboratory on Energy, Water, Environment and Processes, National School of Engineering, Gabes University, Gabes, Tunisia.
Lazhar ZourguiResearch Laboratory BMA LR22ES02, Higher Institute of Applied Biology of Medenine, University of Gabes, Gabes, Tunisia.
Omar AlqawiNational Cancer Institute, Misurata, Libya.
Nabiha MissaouiResearch Laboratory LR21ES03, Oncogenesis and Tumor Progression, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Natural plant-derived compounds are increasingly explored as safer alternatives to chemotherapy due to their multi-targeted anticancer properties. Despite Oman's rich floral biodiversity, data on the anticancer potential of its native species remain limited. Aim: This study examined the cytotoxic, antimigratory, and antiadhesive effects of Methods: Results: The ethanolic extract was rich in1,3-di-O-caffeoylquinic acid (23,366 ppm), rosmarinic acid (3,808 ppm), rutin (2,379 ppm), and luteolin (1,196 ppm).The extract significantly reduced HCT116 cell viability in a dose-dependent manner,from 87.7% at 50 µg/ml to 32.4% at 200 µg/ml ( Conclusion:

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicColorectal NeoplasmsOcimum basilicumPlant ExtractsCell AdhesionCell MovementEthanolHCT116 CellsHumansOmanAntineoplastic AgentsAntineoplastic Agents, PhytogenicEthanolPlant ExtractsColorectal cancerHCT116 cellsNatural anticancer agentOcimum basilicumOman

Identifiers

PMID42376545
PMCPMC13314092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.